Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer

Published:2012-03 Issue:3 Volume:180 Page:895-903
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Sircar Kanishka,Huang Heng,Hu Limei,Cogdell David,Dhillon Jasreman,Tzelepi Vassiliki,Efstathiou Eleni,Koumakpayi Ismaël H.,Saad Fred,Luo Dijun,Bismar Tarek A.,Aparicio Ana,Troncoso Patricia,Navone Nora,Zhang Wei

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2010

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. CYP17 inhibition as a hormonal strategy for prostate cancer;Reid;Nat Clin Pract Urol,2008

5. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression Profiles;2024-08-31

2. Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential;Frontiers in Chemical Biology;2024-06-06

3. Integrated proteomics and metabolomics analysis reveals new insight into the synergistic antitumor effect of valproic acid plus simvastatin in prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling;2024-03-15

4. Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer;International Journal of Molecular Sciences;2024-02-29

5. Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients;Scientific Reports;2023-12-20